Trevi Therapeutics Inc.(TRVI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TRVI Trevi Therapeutics Inc.

休市中 07-25 16:00:00 EDT

7.87

+0.03

+0.38%

盘后7.90

+0.03+0.38%

18:53 EDT

最高7.97	最低7.65	成交量165.49万
今开7.89	昨收7.84	日振幅4.08%
总市值9.38亿	流通市值7.60亿	总股本1.19亿
成交额1,301万	换手率1.71%	流通股本9,653万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TRVI","market":"US","secType":"STK","nameCN":"Trevi Therapeutics Inc.","latestPrice":7.87,"timestamp":1753473600000,"preClose":7.84,"halted":0,"volume":1654925,"hourTrading":{"tag":"盘后","latestPrice":7.9,"preClose":7.87,"latestTime":"18:53 EDT","volume":158770,"amount":1249544.21,"timestamp":1753483996266},"delay":0,"floatShares":96534000,"shares":119144767,"eps":-0.444611,"marketStatus":"休市中","change":0.03,"latestTime":"07-25 16:00:00 EDT","open":7.89,"high":7.97,"low":7.65,"amount":13012883.79555,"amplitude":0.040816,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.444611,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753689600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1557201600000,"exchange":"NASDAQ","adjPreClose":7.84,"preHourTrading":{"tag":"盘前","latestPrice":7.85,"preClose":7.84,"latestTime":"09:27 EDT","volume":295,"amount":2315.249975,"timestamp":1753450070009},"postHourTrading":{"tag":"盘后","latestPrice":7.9,"preClose":7.87,"latestTime":"18:53 EDT","volume":158770,"amount":1249544.21,"timestamp":1753483996266},"volumeRatio":0.6529563811708868,"impliedVol":0.3975,"impliedVolPercentile":0.132},"requestUrl":"/m/hq/s/TRVI","defaultTab":"news","newsList":[{"id":"2538427030","title":"Trevi Therapeutics(TRVI.US)获HC Wainwright & Co.首次覆盖，给予买入评级, 目标价21.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2538427030","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538427030?lang=zh_cn&edition=full","pubTime":"2025-05-28 18:44","pubTimestamp":1748429059,"startTime":"0","endTime":"0","summary":"Trevi Therapeutics(TRVI.US)获HC Wainwright & Co.首次覆盖，给予买入评级, 目标价21.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/28184450719548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TRVI","LENZ"],"gpt_icon":0},{"id":"2536582469","title":"Trevi Therapeutics, Inc.2025财年第一财季实现净利润-10.34百万美元，同比增加5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536582469","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536582469?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497656,"startTime":"0","endTime":"0","summary":"5月18日，Trevi Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-10.34百万美元，同比增加5.14%；其中营业收入为0.00美元，每股基本收益为-0.09美元。从资产负债表来看，Trevi Therapeutics, Inc.总负债7.55百万美元，其中短期债务276000.00美元，资产负债比为0.15，流动比率为0.16。机构评级：截至2025年5月18日，当前有10家机构对Trevi Therapeutics, Inc.目标价做出预测，其中目标均价为18.85美元，其中最低目标价为11.00美元，最高目标价为29.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000514a4821eea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000514a4821eea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TRVI"],"gpt_icon":0},{"id":"2535313032","title":"Trevi Therapeutics, Inc.盘中异动 股价大涨5.25%报6.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535313032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535313032?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:37","pubTimestamp":1747402660,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时37分，Trevi Therapeutics, Inc.股票出现异动，股价快速上涨5.25%。截至发稿，该股报6.52美元/股，成交量6.5777万股，换手率0.06%，振幅4.20%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213740a6e1bac0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213740a6e1bac0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVI","BK4007","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2535201390","title":"Trevi Therapeutics, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535201390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535201390?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:31","pubTimestamp":1747229473,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时31分，Trevi Therapeutics, Inc.股票出现波动，股价快速上涨5.03%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213113a47e3e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213113a47e3e02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","TRVI","BK4007"],"gpt_icon":0},{"id":"1142637442","title":"异动解读 | Trevi Therapeutics盘后大涨5%，Q1业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1142637442","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142637442?lang=zh_cn&edition=full","pubTime":"2025-05-09 07:42","pubTimestamp":1746747751,"startTime":"0","endTime":"0","summary":"生物制药公司Trevi Therapeutics周四盘后股价大涨5%，主要受益于公司发布的第一季度财报好于市场预期。根据公司公布的财报，截至3月31日的第一季度，Trevi Therapeutics调整后每股亏损9美分，优于分析师平均预期的12美分亏损。这一业绩也好于去年同期的11美分亏损。值得注意的是，Trevi Therapeutics股价表现强劲，本季度已上涨5.9%，今年迄今为止更是大涨61.7%。这些因素共同推动了投资者的信心，促使股价在盘后交易中大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Trevi Therapeutics盘后大涨5%，Q1业绩超预期","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TRVI"],"gpt_icon":0},{"id":"2532065209","title":"Trevi Therapeutics, Inc.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532065209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532065209?lang=zh_cn&edition=full","pubTime":"2025-05-01 00:40","pubTimestamp":1746031230,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日00时40分，Trevi Therapeutics, Inc.股票出现波动，股价快速上涨5.07%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501004030a6cf12fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501004030a6cf12fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TRVI","LENZ","BK4007"],"gpt_icon":0},{"id":"2529463826","title":"Trevi Therapeutics, Inc.盘中异动 早盘快速上涨6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529463826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529463826?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:31","pubTimestamp":1745415118,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分，Trevi Therapeutics, Inc.股票出现异动，股价快速拉升6.10%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213159a463f970&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213159a463f970&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","TRVI"],"gpt_icon":0},{"id":"2526832645","title":"Trevi Therapeutics, Inc.盘中异动 临近收盘急速上涨5.02%报5.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526832645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526832645?lang=zh_cn&edition=full","pubTime":"2025-04-12 04:00","pubTimestamp":1744401615,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日04时00分，Trevi Therapeutics, Inc.股票出现波动，股价大幅上涨5.02%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.94%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412040016a45682e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412040016a45682e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TRVI","BK4007"],"gpt_icon":0},{"id":"2518205376","title":"HC Wainwright & Co.：维持Trevi Therapeutics(TRVI.US)评级，由买入调整至买入评级, 目标价由7.50美元调整至12.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518205376","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518205376?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:41","pubTimestamp":1741628499,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Trevi Therapeutics(TRVI.US)评级，由买入调整至买入评级, 目标价由7.50美元调整至12.50美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11014148641576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","TRVI"],"gpt_icon":0},{"id":"2518275991","title":"Trevi Therapeutics, Inc.盘中异动 早盘急速上涨53.49%报6.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275991","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518275991?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:30","pubTimestamp":1741613405,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时30分，Trevi Therapeutics, Inc.股票出现异动，股价大幅拉升53.49%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213005a26a23d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213005a26a23d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TRVI","BK4007","LENZ"],"gpt_icon":0},{"id":"2516666876","title":"Trevi Therapeutics, Inc.盘中异动 急速下挫5.09%报4.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516666876","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516666876?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:14","pubTimestamp":1741032851,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时14分，Trevi Therapeutics, Inc.股票出现波动，股价快速跳水5.09%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304041412abe69252&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304041412abe69252&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","TRVI","LENZ"],"gpt_icon":0},{"id":"2514378194","title":"Trevi Therapeutics, Inc.盘中异动 股价大跌7.33%报4.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514378194?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753062,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Trevi Therapeutics, Inc.股票出现异动，股价急速下挫7.33%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282231029896796a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282231029896796a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","TRVI","BK4139"],"gpt_icon":0},{"id":"2514389009","title":"Trevi Therapeutics, Inc.盘中异动 股价大涨5.10%报4.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514389009?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:20","pubTimestamp":1740669609,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时20分，Trevi Therapeutics, Inc.股票出现异动，股价急速上涨5.10%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227232009abdf7bad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227232009abdf7bad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVI","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2514041811","title":"Trevi Therapeutics, Inc.盘中异动 快速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514041811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514041811?lang=zh_cn&edition=full","pubTime":"2025-02-26 04:58","pubTimestamp":1740517139,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日04时58分，Trevi Therapeutics, Inc.股票出现波动，股价急速上涨5.10%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226045859abdcd5f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226045859abdcd5f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","TRVI","LENZ"],"gpt_icon":0},{"id":"2514702770","title":"Trevi Therapeutics, Inc.盘中异动 下午盘大幅下挫5.54%报4.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514702770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514702770?lang=zh_cn&edition=full","pubTime":"2025-02-25 03:29","pubTimestamp":1740425356,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日03时29分，Trevi Therapeutics, Inc.股票出现异动，股价快速跳水5.54%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225032917962ed3f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225032917962ed3f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRVI","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2513729972","title":"Trevi Therapeutics, Inc.盘中异动 股价大涨5.21%报5.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513729972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513729972?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:30","pubTimestamp":1740148229,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时30分，Trevi Therapeutics, Inc.股票出现异动，股价快速上涨5.21%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223030988dddc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223030988dddc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TRVI","BK4007"],"gpt_icon":0},{"id":"2512435232","title":"Trevi Therapeutics, Inc.盘中异动 快速上涨5.09%报4.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512435232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512435232?lang=zh_cn&edition=full","pubTime":"2025-02-20 03:19","pubTimestamp":1739992789,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日03时19分，Trevi Therapeutics, Inc.股票出现波动，股价快速上涨5.09%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220031949abd53208&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220031949abd53208&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","TRVI","BK4139"],"gpt_icon":0},{"id":"2512193256","title":"Trevi Therapeutics, Inc.盘中异动 急速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512193256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512193256?lang=zh_cn&edition=full","pubTime":"2025-02-19 02:06","pubTimestamp":1739902005,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日02时06分，Trevi Therapeutics, Inc.股票出现波动，股价快速拉升5.04%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219020646988a201e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219020646988a201e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","TRVI"],"gpt_icon":0},{"id":"2510336829","title":"Trevi Therapeutics, Inc.盘中异动 早盘快速下挫5.05%报3.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510336829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510336829?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:19","pubTimestamp":1739287180,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时19分，Trevi Therapeutics, Inc.股票出现波动，股价大幅跳水5.05%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.60%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211231940961f5137&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211231940961f5137&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TRVI","BK4007"],"gpt_icon":0},{"id":"2510186646","title":"Trevi Therapeutics, Inc.盘中异动 早盘快速下挫5.42%报4.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510186646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510186646?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:55","pubTimestamp":1739199338,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时55分，Trevi Therapeutics, Inc.股票出现波动，股价快速下跌5.42%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225538abc9ab54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225538abc9ab54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRVI","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.trevitherapeutics.com","stockEarnings":[{"period":"1week","weight":0.1472},{"period":"1month","weight":0.3856},{"period":"3month","weight":0.2164},{"period":"6month","weight":1.0128},{"period":"1year","weight":1.4826},{"period":"ytd","weight":0.9102}],"compareEarnings":[{"period":"1week","weight":0.0152},{"period":"1month","weight":0.0494},{"period":"3month","weight":0.157},{"period":"6month","weight":0.0479},{"period":"1year","weight":0.1833},{"period":"ytd","weight":0.0871}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Trevi Therapeutics, Inc.于2011年3月17日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发和商业化纳布啡ER，以治疗严重的神经介导的疾病。该公司目前正在开发纳布啡ER，用于治疗患有特发性肺纤维化或IPF的慢性瘙痒，慢性咳嗽，以及帕金森病患者的左旋多巴诱导的运动障碍或LID。这些病症具有共同的病理生理学，其通过中枢和外周神经系统中的阿片受体介导。由于纳布啡作为阿片受体调节剂的作用机制，该公司认为这有可能有效治疗这些疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.099656},{"month":2,"riseRate":0.833333,"avgChangeRate":0.203564},{"month":3,"riseRate":0.5,"avgChangeRate":0.396594},{"month":4,"riseRate":0.5,"avgChangeRate":0.125322},{"month":5,"riseRate":0,"avgChangeRate":-0.128619},{"month":6,"riseRate":0.714286,"avgChangeRate":0.210852},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.001178},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.08811},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.120284},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.120364},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.07561},{"month":12,"riseRate":0.666667,"avgChangeRate":0.048916}],"exchange":"NASDAQ","name":"Trevi Therapeutics Inc.","nameEN":"Trevi Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Trevi Therapeutics Inc.(TRVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Trevi Therapeutics Inc.(TRVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Trevi Therapeutics Inc.,TRVI,Trevi Therapeutics Inc.股票,Trevi Therapeutics Inc.股票老虎,Trevi Therapeutics Inc.股票老虎国际,Trevi Therapeutics Inc.行情,Trevi Therapeutics Inc.股票行情,Trevi Therapeutics Inc.股价,Trevi Therapeutics Inc.股市,Trevi Therapeutics Inc.股票价格,Trevi Therapeutics Inc.股票交易,Trevi Therapeutics Inc.股票购买,Trevi Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Trevi Therapeutics Inc.(TRVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Trevi Therapeutics Inc.(TRVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}